These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27256188)

  • 1. Can the success of structured therapy for giggle incontinence be predicted?
    Telli O; Hamidi N; Kayis A; Suer E; Soygur T; Burgu B
    Int Braz J Urol; 2016; 42(2):334-8. PubMed ID: 27256188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment for giggle incontinence with biofeedback.
    Richardson I; Palmer LS
    J Urol; 2009 Oct; 182(4 Suppl):2062-6. PubMed ID: 19695635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate for giggle incontinence.
    Berry AK; Zderic S; Carr M
    J Urol; 2009 Oct; 182(4 Suppl):2028-32. PubMed ID: 19695642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding.
    't Hoen LA; van den Hoek J; Wolffenbuttel KP; van der Toorn F; Scheepe JR
    J Pediatr Urol; 2015 Jun; 11(3):119.e1-6. PubMed ID: 25794865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback.
    Tugtepe H; Thomas DT; Ergun R; Kalyoncu A; Kaynak A; Kastarli C; Dagli TE
    J Pediatr Urol; 2015 Jun; 11(3):137.e1-5. PubMed ID: 25824876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacies of methylphenidate and biofeedback treatments in giggle incontinence: One-year follow-up study.
    Hacıislamoğlu A; Ekşi M; Özlü DN; Yavuzsan AH; Evren İ; Karadağ S; Polat H; Kargı T; Taşçı Aİ
    J Pediatr Urol; 2021 Oct; 17(5):646.e1-646.e5. PubMed ID: 34417132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program.
    Meijer EF; Nieuwhof-Leppink AJ; Dekker-Vasse E; de Joode-Smink GC; de Jong TP
    J Pediatr Urol; 2015 Feb; 11(1):21.e1-5. PubMed ID: 25205144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and urodynamic effect of methylphenidate for the treatment of giggle incontinence (enuresis risoria).
    Chang JH; Lee KY; Kim TB; Yoon SJ; Lee T; Kim KH
    Neurourol Urodyn; 2011 Sep; 30(7):1338-42. PubMed ID: 21520251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giggle incontinence in children: a manifestation of detrusor instability.
    Chandra M; Saharia R; Shi Q; Hill V
    J Urol; 2002 Nov; 168(5):2184-7; discussion 2187. PubMed ID: 12394756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methylphenidate for giggle incontinence in children.
    Svendsen AM; Kamperis K; Hagstroem S; Thorsteinsson KN; Arvad M; Borch L
    Neurourol Urodyn; 2023 Sep; 42(7):1470-1475. PubMed ID: 37376840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined functional pelvic floor muscle exercises with Swiss ball and urotherapy for management of dysfunctional voiding in children: a randomized clinical trial.
    Ladi Seyedian SS; Sharifi-Rad L; Ebadi M; Kajbafzadeh AM
    Eur J Pediatr; 2014 Oct; 173(10):1347-53. PubMed ID: 24844352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timer watch assisted urotherapy in children: a randomized controlled trial.
    Hagstroem S; Rittig S; Kamperis K; Djurhuus JC
    J Urol; 2010 Oct; 184(4):1482-8. PubMed ID: 20727552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine for refractory daytime incontinence in the pediatric population.
    Franco I; Arlen AM; Collett-Gardere T; Zelkovic PF
    J Pediatr Urol; 2018 Feb; 14(1):58.e1-58.e5. PubMed ID: 29100969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of day-time urinary incontinence in children.
    Hagstroem S; Rittig N; Kamperis K; Mikkelsen MM; Rittig S; Djurhuus JC
    Scand J Urol Nephrol; 2008; 42(6):528-33. PubMed ID: 18609267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is urotherapy alone as effective as a combination of urotherapy and biofeedback in children with dysfunctional voiding?
    Altunkol A; Abat D; Sener NC; Gulum M; Ciftci H; Savas M; Yeni E
    Int Braz J Urol; 2018; 44(5):987-995. PubMed ID: 30130020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of alpha1-adrenergic blockers in boys with low urinary flow rate and urinary incontinence.
    Yang SS; Wang CC; Chen YT
    J Formos Med Assoc; 2003 Aug; 102(8):551-5. PubMed ID: 14569320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary incontinence during laughter in children: Is it giggle incontinence?
    San ST; Barnes EH; Caldwell PHY
    J Paediatr Child Health; 2021 Dec; 57(12):1971-1975. PubMed ID: 34170589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison and characteristics of children successfully treated for daytime urinary incontinence.
    Jessen AS; Hagstroem S; Borch L
    J Pediatr Urol; 2022 Feb; 18(1):24.e1-24.e9. PubMed ID: 34930690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA; Gitlin J; Toro S; Palmer LS
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.